[Federal Register: June 2, 2009 (Volume 74, Number 104)]
[Notices]
[Page 26404-26406]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02jn09-68]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-09-0920-09BQ]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
[[Page 26405]]
opportunity for public comment on proposed data collection projects,
the Centers for Disease Control and Prevention (CDC) will publish
periodic summaries of proposed projects. To request more information on
the proposed projects or to obtain a copy of the data collection plans
and instruments, call 404-639-5960 and send comments to Maryam I.
Daneshvar, CDC Acting Reports Clearance Officer, 1600 Clifton Road, MS-
D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Examining In-vehicle Exposures to Air Pollutants and Corresponding
Health Outcomes of Commuters--New--National Center for Environmental
Health, (NCEH) and Agency for Toxic Substances and Disease Registry
(ATSDR), Centers for Disease Control and Prevention, (CDC).
Background and Brief Description
Numerous studies have found associations between ambient fine
particulate matter (PM2.5) and adverse cardiovascular
outcomes. Several recent epidemiologic studies suggest that vehicle-
related emissions, in particular, may be linked to many of the these
adverse effects and that specific sub-populations may be more
susceptible to health risks due to their enhanced exposures to vehicle-
related PM2.5 sources. Commuters are a potentially
susceptible, yet poorly characterized, sub-population. Importantly,
recent epidemiologic studies indicate that specific sub-groups,
including those with asthma, may be at risk to cardiorespiratory health
effects due to their pre-existing health condition. A more complete
understanding of in-vehicle exposures for the commuter population,
especially those with asthma, is therefore becoming increasingly
necessary as commuting durations and roadway congestion have steadily
increased throughout the U.S. during the last 20 years. The National
Center for Environmental Health (NCEH), Centers for Disease Control and
Prevention (CDC) will conduct this study to characterize in-vehicle
exposures to traffic-related air pollutants among commuters, with and
without asthma, and any health impacts that these exposures may have on
the commuter.
A total of 40 participants (20 adults with physician-diagnosed
asthma and 20 healthy adults) living in the Atlanta metro area will be
recruited for participation in this study. Participants will be
excluded if they meet specific criteria including: ever being diagnosed
with severe asthma, ever suffering a myocardial infarction, smoking
tobacco products, or ever being diagnosed with a pulmonary disease such
as emphysema, COPD, or any type of lung cancer.
Approximately one week prior to their scheduled commute,
participants will complete a one-time baseline questionnaire to assess
medical history and general exposures. Additionally, a short symptom
diary recording any respiratory symptoms will be completed by the
participant each day for the seven days prior to the commute and on the
day of the commute. On the day of the planned commute, health
measurements for lung function, lung inflammatory markers, heart rate,
and biomarkers of systemic inflammation will also be conducted by a
trained field technician. In-vehicle exposures to particulate matter
and other air pollutants will then be measured for all participants
during their commute. After the commute, the symptom diary and health
measurements will be conducted again to assess any potential changes in
respiratory and cardiovascular health effects. The information learned
from the health measurements and diary entries before and after the
commute will be important in better understanding the potential acute
health impacts associated with exposures to in-vehicle traffic
pollutants and respiratory and cardiovascular health, and whether urban
commuters--especially those with asthma--should be viewed as a
susceptible sub-population given their enhanced exposures to
PM2.5 and gas-phased pollutants.
There is no cost to participants other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Instrument type Respondents respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Baseline questionnaire........ Eligible 40 1 30/60 20
participants
with and
without asthma.
Symptom diary................. Eligible 40 8 5/60 27
participants
with and
without asthma.
Total..................... ................ .............. .............. .............. 47
----------------------------------------------------------------------------------------------------------------
[[Page 26406]]
Dated: May 26, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E9-12746 Filed 6-1-09; 8:45 am]
BILLING CODE 4163-18-P